Cott (TSE:PRM) Upgraded at BMO Capital Markets

BMO Capital Markets upgraded shares of Cott (TSE:PRM) to a strong-buy rating in a research note published on Monday,Zacks.com reports.

Other analysts have also issued reports about the stock. William Blair upgraded shares of Cott to a “strong-buy” rating in a research report on Thursday, October 24th. Raymond James downgraded shares of Cott from a “moderate buy” rating to a “hold” rating in a research report on Wednesday, October 2nd.

Cott Stock Up 0.7 %

Cott stock opened at C$13.39 on Monday. Cott has a 52-week low of C$12.95 and a 52-week high of C$14.97. The company’s 50-day moving average price is C$13.25.

Cott Announces Dividend

The business also recently disclosed a None dividend, which was paid on Thursday, November 21st. Stockholders of record on Tuesday, November 5th were given a dividend of $1.109 per share. The ex-dividend date of this dividend was Tuesday, November 5th.

Cott Company Profile

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.